Why is Liver Injury (DILI) the Most Frequent Reason for a Drug Being Pulled from the Market

Duration: 90 Minutes
Ferreting out which Investigational Medicinal Products (IMP) might cause significant liver injury is not an easy process partly because there is confusion about how to test for liver injury and part because these AEs are rare (in the 1:10,000+ area) or "idiosyncratic" in type so are not picked up in the usual drug development process testing. We all know that AE’s are one of the key ways the Clinical Investigator has of monitoring the safety of subjects or patients in her/his charge but some are very rare so the Investigators must be ‘heads-up’. Add to this, the large number of "non-drug liver injuries, which easily confound the issue. To be forewarned is forearmed.
Drug Induced Liver Injury
Product ID: 500204

Determining the relationship between the study drug and an AE requires a practiced power of observation & great care (good medical judgment). Determining if an IMP is subject to liver injury separates the best PI’s from the rest.

The recent media publicity of the FDA warnings about the OTC drug acetaminophen, which is the most common drug cause for liver transplants has brought into focus the effects of drugs on the liver.

Why Should you Attend:
Whereas Drug Induced Liver Injury (DILI) is usually a rare event that is not found in the usually approval process, there are clues that all investigators and study staff must know. These will be reviewed in this Webinar.

Objectives of the Presentation:
  • When is an abnormal lab value an AE?
  • What are Liver Function Tests?
  • Drug effects on the liver in perspective
  • Where does acetaminophen (Tylenol) toxicity fit in this process?
  • What are the risk and host factors for Drug Induced Liver Injury?
  • How and when do we detect "rare" events?
  • What are the types of the liver’s response to drugs?
  • How do ‘non-drug liver injuries fit in the concept of DILI
Who can Benefit:
  • The Pharmaceutical and Biological Industry who sponsor pre-approval clinical research and who are responsible for the outcome of the studies
  • Principal Investigators and Sub investigators
  • Clinical Research Scientists (PKs, Biostatisticians, ...)
  • Research Managers
  • Safety Nurses
  • Clinical Research Associates (CRAs) and Coordinators (CRCs)
  • Recruiting Staff
  • QA / QC Auditors and Staff
  • Study Monitors
  • Clinical Research Data Managers.
$300
Recorded Session for one participant
Get life time access with download option!
Book this course
Pay Now
  $450.00 Training CD
Free shipment within 4 Working Days of placing the order. Get life time access for unlimited participants.
  $550.00 Training USB Flash Drive
Free shipment within 4 Working Days of placing the order. Get life time access for unlimited participants.
For multiple location please contact our customer care team +1-510-857-5896.
How it works
Live Session - How it works
  • Login to onlinecompliancepanel with your registered username and password https://www.onlinecompliancepanel.com/login
  • The webinar joining link, username and password for joining the webinar will be updated on your OCP Account 24 hours prior to the webinar
  • Presentation handouts in Downloadable PDF format will be updated on your OCP Account 24 hours prior to the live session
  • Login to the audio conference on the scheduled date and time
  • Get answers to your queries through interactive Q&A sessions via chat at the end of the session
  • Download the Certificate of Attendance and Purchase Invoice from your OCP Account 24 hours after the completion of the session
  • Please let us know your thoughts and views at the end of the webinar, your valuable feedback will help us improve
Recorded Session - How it works
  • Login to onlinecompliancepanel with your registered username and password https://www.onlinecompliancepanel.com/login
  • Upon purchase of the recorded session a link will be updated on your OCP Account within 24 hours
  • Please click on the link to access the Recorded Session
  • Presentation handouts in downloadable PDF format will be updated on your OCP Account within 24 hours of the purchase of the product
  • Download the Certificate of Attendance and Purchase Invoice from your OCP Account after 48 hours of the product Purchase
  • Please share your valuable Feedback at the end of the session
Instructor Profile:
Charles H Pierce is President of the virtual CRO Global Clinical Partners, Inc and Pierce One Consulting. From an original Master’s thesis (Pharmacology) in 1961 (Minnesota) through a Doctorate in Surgery-Pharmacology in 1974 (Saskatchewan) and continuing throughout 45+ years in the practice of clinical medicine as a family physician (7 years as an ER doc) and 25+ years in the medical research industry (7 years as a Principal Investigator), Charles has an experienced based knowledge of the Clinical Research part of Drug Development.

He is an APPI/APCR Certified Principal Investigator (CPI in 2003 and recertification’s to 2016). He is actively involved in Webinars, courses and workshops.

Charles’ active management experience in the medical research industry gives him first-hand practical experience and knowledge to develop Phase I, IIa confined study Clinical Pharmacology Units (CPU’s). Charles is a Fellow and Life Member of the American Academy of Family Physicians and Emeritus fellow of the American College of Clinical Pharmacology (ACCP) and the 2004 recipient of the Nathaniel Kwitt Distinguished Service Award. He is an active member of the Association of Clinical Pharmacology Units (ACPU). He is also a member of the Academy of Physicians in Clinical Research (APCR) and the 2012 Chair of the Board to trustees of the Academy of the Association of Clinical Research Professionals (ACRP).
View More